CAS: 1056901-62-2 - AT13148
Ref: IN-DA008TDL
| 5mg | 221.00 € | ||
| 25mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
AT13148
CAS:1056901-62-2
AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1/2/3, p70S6K, PKA, and ROCKI/II.
Formula:
C17H16ClN3O
Purity:
98.04% - ≥95%
Color and Shape:
Solid
Molecular weight:
313.78
- Inhibitors
- ROCK
- Stem Cell and Derivatives
- Stem Cells
- See more categories
- PKA
Ref: TM-T2482
| 1mg | 48.00 € | ||
| 2mg | 67.00 € | ||
| 5mg | 117.00 € | ||
| 10mg | 189.00 € | ||
| 25mg | 329.00 € | ||
| 50mg | 476.00 € | ||
| 1mL*10mM (DMSO) | 126.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
(S)-1-(4-(1H-Pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethanol
CAS:1056901-62-2
Purity:
95.0%
Color and Shape:
Solid
Molecular weight:
313.7900085449219
Ref: 10-F459624
| 5mg | To inquire | ||
| 25mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 18 Dec 2024
AT-13148
Controlled ProductCAS:1056901-62-2
Formula:
C17H16ClN3O
Color and Shape:
Neat
Molecular weight:
313.781
Ref: TR-A790350
| 25mg | 20,214.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
AT 13148
CAS:1056901-62-2
Inhibitor of ROCK I and ROCK II kinases; multi-AGC kinase inhibitor
Purity:
Min. 95%
Ref: 3D-FA137648
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
